您的购物车当前为空
别名 SETD2-IN-1 TFA, IPN-60210 TFA
EZM0414 TFA (SETD2-IN-1 TFA) 是一种具有口服活性和选择性的人类组蛋白甲基转移酶 SETD2 抑制剂,具有抗癌和抗增殖作用,可用于研究白血病和免疫功能异常。

EZM0414 TFA (SETD2-IN-1 TFA) 是一种具有口服活性和选择性的人类组蛋白甲基转移酶 SETD2 抑制剂,具有抗癌和抗增殖作用,可用于研究白血病和免疫功能异常。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 1,660 | 5日内发货 |
EZM0414 TFA 相关产品
| 产品描述 | EZM0414 TFA (SETD2-IN-1 TFA) is a SETD2 inhibitor with anticancer and antiproliferative effects for the study of leukemia and immune dysfunction. |
| 别名 | SETD2-IN-1 TFA, IPN-60210 TFA |
| 分子量 | 514.51 |
| 分子式 | C24H30F4N4O4 |
| CAS No. | 2411759-92-5 |
| Smiles | OC(=O)C(F)(F)F.CC(=O)N1CCN(CC1)[C@H]1CCC[C@H](C1)NC(=O)c1cc2c(F)ccc(C)c2[nH]1 |
| 颜色 | White |
| 物理性状 | Solid |
| 存储 | keep away from moisture,store under nitrogen | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||||||||||||||||||||||
| 溶解度信息 | H2O: 2 mg/mL (3.89 mM), Sonication is recommended. DMSO: 120 mg/mL (233.23 mM), Sonication is recommended. | ||||||||||||||||||||||||||||||||||||||||
溶液配制表 | |||||||||||||||||||||||||||||||||||||||||
H2O/DMSO
DMSO
| |||||||||||||||||||||||||||||||||||||||||
评论内容